16.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$16.88
Aprire:
$16.76
Volume 24 ore:
208.21K
Relative Volume:
0.56
Capitalizzazione di mercato:
$767.83M
Reddito:
$502.79M
Utile/perdita netta:
$23.71M
Rapporto P/E:
33.06
EPS:
0.5
Flusso di cassa netto:
$6.35M
1 W Prestazione:
-5.88%
1M Prestazione:
-15.91%
6M Prestazione:
+32.13%
1 anno Prestazione:
+19.41%
Core Laboratories Inc Stock (CLB) Company Profile
Nome
Core Laboratories Inc
Settore
Industria
Telefono
713-328-2673
Indirizzo
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, TS, FTI
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CLB
Core Laboratories Inc
|
16.49 | 785.99M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Slb Ltd
|
48.11 | 72.64B | 35.69B | 3.45B | 4.54B | 2.3617 |
|
BKR
Baker Hughes Company
|
60.94 | 61.80B | 27.73B | 2.62B | 2.54B | 2.605 |
|
HAL
Halliburton Co
|
34.40 | 29.53B | 22.18B | 1.29B | 1.67B | 1.5088 |
|
TS
Tenaris S A Adr
|
53.66 | 26.73B | 11.84B | 2.03B | 1.68B | 3.7282 |
|
FTI
Technipfmc Plc
|
65.61 | 26.45B | 9.93B | 967.10M | 1.45B | 2.3076 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-06-30 | Downgrade | Citigroup | Neutral → Sell |
| 2023-04-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-09-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Downgrade | Citigroup | Neutral → Sell |
| 2020-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Reiterato | Cowen | Market Perform |
| 2020-10-13 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Aggiornamento | ABN Amro | Sell → Hold |
| 2020-07-16 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Reiterato | Cowen | Market Perform |
| 2020-01-30 | Ripresa | Johnson Rice | Buy |
| 2020-01-14 | Iniziato | Bernstein | Mkt Perform |
| 2020-01-02 | Downgrade | Stifel | Buy → Hold |
| 2019-12-31 | Reiterato | Cowen | Market Perform |
| 2019-07-10 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Aggiornamento | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2018-11-01 | Aggiornamento | ABN Amro | Sell → Buy |
| 2018-10-29 | Reiterato | Cowen | Market Perform |
Mostra tutto
Core Laboratories Inc Borsa (CLB) Ultime notizie
Core Laboratories Delays 2025 Annual 10-K Filing - TipRanks
Core Laboratories (CLB) delays 2025 10-K amid international tax, control review - Stock Titan
CLB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Q1 EPS Forecast for Core Laboratories Lifted by Analyst - Defense World
CLB (Core Laboratories) ROC % : 5.95% (As of Dec. 2025) - GuruFocus
Core Laboratories (NYSE:CLB) Shares Surge Past Key Trend Line Nyse Composite Today - Kalkine Media
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Is Core Laboratories Inc. stock worth buying before Fed action2025 Retail Activity & Low Risk High Win Rate Stock Picks - mfd.ru
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNIN - GuruFocus
Core Labs Jumps 79% in 6 Months: Time to Buy or Stay on the Sidelines? - Finviz
Core Laboratories (CLB) grants 7,526 performance share units to CAO Teo Sow Hang - Stock Titan
Disciplined Growth Investors boosts Core Laboratories (CLB) stake to 11.1% - Stock Titan
Is Core Laboratories Inc. stock safe for risk averse investorsJuly 2025 Action & Free High Accuracy Swing Entry Alerts - mfd.ru
Will Core Laboratories Inc. stock recover faster than peersJuly 2025 Macro Moves & Verified Momentum Stock Ideas - mfd.ru
Core Laboratories (NYSE:CLB) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Will Core Laboratories Inc. stock keep outperforming rivalsM&A Rumor & Short-Term Swing Trade Alerts - mfd.ru
Core Laboratories : Lab Celebrates 90 Years of Innovation, Insights & Impact - marketscreener.com
Can Core Laboratories Inc stock outperform in a bear marketTrade Ideas & Long-Term Capital Growth Ideas - baoquankhu1.vn
Core Laboratories Inc.: - marketscreener.com
Can Core Laboratories Inc. benefit from deglobalizationJuly 2025 Summary & Free Real-Time Volume Trigger Notifications - mfd.ru
Core Laboratories Q4 Earnings Call Highlights - Defense World
Core Laboratories outlines Q1 2026 guidance of $124M–$130M revenue amid strong international demand and cost challenges - MSN
Core Laboratories N.V. (NYSE:CLB) Q4 2025 Earnings Call Transcript - Insider Monkey
Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y - TradingView
Core Laboratories to Announce Q4 Earnings on February 4 - Intellectia AI
Core Laboratories Stock Under Pressure: Is This Energy Services Veteran a Contrarian Buy or a Value - AD HOC NEWS
Core Laboratories (NYSE:CLB) Shares Down 12%Here's Why - MarketBeat
Core Lab (CLB) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Core Laboratories Q4 2025 earnings miss forecasts By Investing.com - Investing.com Canada
Core Laboratories Inc. (NYSE:CLB) Declares Quarterly Dividend of $0.01 - MarketBeat
Core Laboratories Stock Finds Its Footing: Modest Rebound Amid Cautious Energy Sentiment - AD HOC NEWS
Core Laboratories (CLB) Anticipates Q1 Revenue Between $124M and $130M - GuruFocus
Core Laboratories (CLB) Exceeds Revenue Expectations in Q4, Boos - GuruFocus
Core Laboratories (NYSE:CLB) Announces Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Core Laboratories: Fourth Quarter Earnings Overview - Bitget
Core Laboratories: Q4 Earnings Snapshot - KTEN
Core Laboratories (NYSE:CLB) Releases Q1 2026 Earnings Guidance - MarketBeat
Core Laboratories expects Q1 rev between $124 mln to $130 mln - marketscreener.com
Core Laboratories posts Q4 2025 results and dividend - TipRanks
(CLB) Core Laboratories Inc. Expects Q1 Revenue Range $124.0M$130.0M - marketscreener.com
Earnings Flash (CLB) Core Laboratories Inc. Reports Q4 Revenue $138.3M, vs. FactSet Est of $132.1M - marketscreener.com
Earnings Flash (CLB) Core Laboratories Inc. Posts Q4 Adjusted EPS $0.21 per Share, vs. FactSet Est of $0.19 - marketscreener.com
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - PR Newswire
Quarterly Earnings: Is Core Laboratories Inc. stock positioned for digital transformation2025 Price Targets & Long-Term Growth Stock Strategies - mfd.ru
Investors in Core Laboratories (NYSE:CLB) have unfortunately lost 47% over the last five years - Yahoo Finance
What's in Store for Core Laboratories Stock in Q4 Earnings? - Yahoo Finance
Is Core Laboratories Inc.'s (NYSE:CLB) Latest Stock Performance A Reflection Of Its Financial Health? - 富途牛牛
Core Laboratories (CLB) Expected to Announce Earnings on Wednesday - MarketBeat
EPS Watch: Can Core Laboratories Inc be the next market leaderMarket Volume Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Core Laboratories Inc Azioni (CLB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):